Intco Medical Soars 6.34%, Hits Intraday High of CNY 51.73

Intco Medical Technology Co., Ltd. has shown significant activity today, achieving a notable gain of 6.34% on March 9, 2026. The stock reached an intraday high of CNY 51.73, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. Over the past year, Intco Medical has outperformed the broader market, generating a return of 83.13%, compared to the China Shanghai Composite's return of 21.47%. The company's financial metrics indicate robust growth, with profits rising by 127.6% and a return on equity (ROE) of 6.76%. Additionally, the operating cash flow reached its highest level at CNY 2,119.78 million, and raw material costs have decreased by 10.74% year-over-year. Intco Medical's market capitalization stands at CNY 18,343 million, positioning it as a large-cap player in its industry. The stock's price-to-book ratio is 1.37, and it offers a dividend yield of 0.39%. With a strong performance over various time frames, including a 24.96% year-to-date increase, Intco Medical continues to demonstrate resilience and growth in a competitive market landscape.